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Abstract: The breakdown of cardiac self-organization leads to heart diseases and failure, the 
number one cause of death worldwide. The left ventricular pressure–volume relation plays a key 
role in the diagnosis and treatment of heart diseases. Lumped-parameter models combined with 
pressure–volume loop analysis are very effective in simulating clinical scenarios with a view to 
treatment optimization and outcome prediction. Unfortunately, often invoked in this analysis is the 
traditional, time-varying elastance concept, in which the ratio of the ventricular pressure to its volume 
is prescribed by a periodic function of time, instead of being calculated consistently according to the 
change in feedback mechanisms (e.g., the lack or breakdown of self-organization) in heart diseases. 
Therefore, the application of the time-varying elastance for the analysis of left ventricular assist device 
(LVAD)–heart interactions has been questioned. We propose a paradigm shift from the time-varying 
elastance concept to a synergistic model of cardiac function by integrating the mechanical, electric, 
and chemical activity on microscale sarcomere and macroscale heart levels and investigating the effect 
of an axial rotary pump on a failing heart. We show that our synergistic model works better than the 
time-varying elastance model in reproducing LVAD–heart interactions with sufficient accuracy to 
describe the left ventricular pressure–volume relation. 
Keywords: cardiac function; modeling; self-organization; lumped-parameter model; left ventricular 
pressure–volume relation; LVAD 
1. Introduction 
Self-organization is a novel phenomenon in complex systems, whereby a macroscopic order 
emerges and is maintained in the midst of complexity [1]. One remarkable manifestation of 
self-organization is homeostasis in biosystems, known to be absolutely critical to the sustainability of 
living organisms. As one of most beautiful and important examples of self-organized biosystems [2], 
the human heart is a mechanical pump acting as a main force driving blood throughout the body via 
the circulatory system, supplying oxygen and nutrients to the tissues, and removing carbon dioxide 
and other waste products. The action of this mechanical pump is tightly regulated and is self-organized 
by feedback mechanisms among mechanical, electric, and chemical activities. Furthermore, cardiac 
function is self-organized and synchronized across scales, from microscale sarcomere to macroscale 
organ levels. Unfortunately, the breakdown of self-organization leads to heart diseases and failure, the 
number one cause of death worldwide. 
Mechanical circulatory support with rotary blood pumps, such as HeartMate II (an axial pump 
manufactured by Thoratec Corporation, Pleasanton, CA, USA) [3] and HeartWare ventricular assist 
device (HVAD: a centrifugal pump manufactured by Medtronic, Minneapolis, MN, USA) [4], is a 
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recognized treatment for advanced heart failure patients, either as a bridge to transplant or recovery or 
ultimately as a long-term solution for noneligible candidates (destination therapy). Although very 
successful, the insertion of a left ventricular assist device (LVAD) remains associated with complications 
such as pump thrombosis, stroke, bleeding, and right heart failure, which affect outcomes [5–10]. It is, 
thus, crucial to increase our understanding of feedback mechanisms and heart–LVAD interactions. 
The single most powerful measure to understand heart function and differentiate normal from 
pathological heart, as well as to diagnose or treat different cardiac pathology, is the relation between 
left ventricular pressure and volume—the so-called P–V loop. In particular, pressure–volume relation 
applied to lumped-parameter representation of the cardiovascular system has important clinical 
applications [6,11], owing to great flexibility in simulating the hemodynamics of different cardiovascular 
conditions and therapeutic interventions at a low computational cost, facilitating a personalized 
therapy [11]. However, the traditional approach heavily relies on the time-varying elastance model [11– 
16], where the ratio of the pressure to the volume (minus the ventricular volume at zero pressure) is 
prescribed as a periodic (double-Hill) function of time for a given heart rate, varying between given Emax 
(the maximum value of E) and minimum Emin (the minimum value of E). Although the time-varying 
elastance model has been useful in understanding the pressure–volume relation in different types of 
mammals, it is empirically based on (almost) physiological data where the heart is regulated internally. 
Thus, its validity in extreme, pathological conditions (such as in [17] in a study on mice) is questionable. 
For instance, when heart rhythm is not regular but chaotic (as in the case of fibrillation), elastance 
will also be chaotic rather than a simple periodic function. This issue is particularly important for 
the treatment of a failing heart requiring the insertion of a LVAD. In particular, since the device is 
connected in parallel between the aorta and the left ventricle to relieve its load, it is very likely to 
disturb or at least alter the status of the heart. There has been indeed some evidence against the validity 
of the time-varying elastance model with an assist device [18]. 
To face this challenge, in this paper, we propose a synergistic model which couples mechanical, 
electric, and chemical activity on microscale sarcomere and macroscale heart levels and investigate the 
effect of an axial rotary pump (e.g., Heart Mate II) on a failing heart. Our focus is to find an alternative 
method that is readily available within the constraints of the clinical environment. Lumped-parameter 
models are well suited for this purpose. We, thus, develop a comparable lumped-parameter model 
that predicts a P–V loop and LVAD–heart interaction by evolving left ventricular pressure and volume 
simultaneously at the minimum computational cost, instead of using the time-varying elastance concept. 
Specifically, we propose the two types, which have the same mechanical or chemical and electric 
activity set up but different circulation models. depending on the coupling between the left ventricle 
and the systemic arterial circulation—the basic (extended) model without (with) coupling to the 
systemic arterial circulation. Our models consist of 9 or 12 ordinary differential equations, and thus 
require significantly less computational resources and time compared with more advanced models [19] 
governed by partial differential equations. In particular, [19] simulated left ventricular fluid–solid 
mechanics through the cardiac cycle under LVAD support. CircAdapt [20] is another example of 
advanced models incorporating electric and sarcomere dynamics, but a systematic study with LAVD 
seems lacking. 
2. Materials and Methods 
2.1. Mechanical/Chemical Model 
On a microscale, we utilize the Bestel–Clement–Sorine (BCS) model of the dynamics of the 
dεccontractile element [21–23] to evolve the active stress τc, stiffness kc, strain εc, and its velocity vc = dt . 
In the BCS model, the active force derives from the chemical activity (e.g., ATP) modeled by u (measured 
in s−1). The governing equations for vc, εc, τc, and kc are then as follows: ⎛ ⎞ 
dvc V 
= −χvc − ω20εc − aτcd0(εc) + b 
⎜⎜⎜⎜ − 1 ⎟⎟⎟⎟ (1)⎝ ⎠,dt V0 
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dεc 
= vc, (2)dt
dτc 
= kcvc − (αl|vc| + |u|)τc + σ0uΘ(u), (3)dt 
dkc 
= −(αl|vc| + |u|)kc + k0uΘ(u), (4)dt 
d0(εc) = exp (−β0 (εc)2). (5) 
Here, Θ(u) is a Heaviside function that takes the value of 1 for u > 0 or 0 otherwise. The evolution 
of vc in Equation (1) involves a damping force χvc, a harmonic force ω2εc, an active force aτcd0(εc),√ 0
and a passive force b( V/V0−1), where χ, a, b, αl are positive constants. Here, ω0 is a microscale, 
high-oscillation frequency. Equation (1) is based on a simplified model of a cylindrical heart with 
a constant height [23], where the left ventricular volume V is related to the strain ε as a square √ 
root ε ∝ V. In Equations (3) and (4), the term involving αl|vc| + |u| represents the deactivation of 
contractile force, while the term involving uΘ(u) represents its activation due to a chemical input u > 0. 
Additionally, d0(εc) in Equations (1) and (5) represents the length–tension curve of the contractile 
element, which we model using a Gaussian function for simplicity. The form of Equations (1)–(4) is 
identical to the BCS model. 
To further link microscale dynamics in Equations (1)–(5) to macroscale dynamics, we relate τc in 
Equations (1) and (3) to the left ventricular pressure PV [23]: 
V0PV = γ [d0(εc)τc + σP], (6)V  k2σP = [exp(k1 V/V0 − 1) − 1], (7)k1 
where σP represents the passive stress, which is assumed to be exponential in Equation (7) for simplicity; 
k1 and k2 are non-negative parameters for the passive tension. In Equation (6), γ is a constant parameter 
proportional to the ratio of left ventricular wall thickness to its radius, and its physiological meaning is 
provided in [21]. For our purpose of coupling microscale and macroscale dynamics, it suffices to treat 
this constant as a parameter proportional to the above ratio and tune it. 
2.2. Electric Activity Model 
We now link the chemical activity u in Equations (3) and (4) to the electric activity. To this end, we 
adapt the forced Van der Pol [2] and FitzHugh–Nagumo [24] models for our convenience (the precise 
form is not particularly important, given the nonlinearity of the equations), as follows: 
dp 
= 0.1(q − p + µ1τc), (8)dt
 
dq  2 2
 = 10q 1 − q − 10(2π) p + µ2VΘ(V − V0) + 10 cos(2πt), (9)dt 
u = αuq, (10) 
where p and q are dimensionless slow and fast variables for the electric activity, respectively; 10 cos(2πt) 
in Equation (9) represents the force with 1 Hz frequency, which we fix to model a normal heart with 
heart rate 1 Hz as a control case. Equation (10) represents the chemical activity u proportional to electric 
activity (q) with a proportional constant αu > 0. Here, µ1 and µ2 in Equations (8) and (9) represent 
the mechano-electric feedback (MEF) [25–29]. The non-zero value of µ1 or µ2 introduces the coupling 
between (p, q) and τc or V. Specifically, µ1 mimics the effect of mechanical stress due to shortening 
during a contraction on the action potential and is motivated by [25]; µ2 models the effect of stretch 
(e.g., through a stretch-activated ion channel) [28]. Biologically, the values of µ1 and µ2 could be 
changed due to the over or under expression of an ion channel. The units of µ1 and µ2 are kpa−1 and 
(s·mL)−1, respectively. Since the role of MEF in a beating heart is implicit, we are uncertain about the 
absolute value or sign of µ1 and µ2 for a control case. However, we find that µ1 = 0.0024 kpa−1 gives a 
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reasonable relaxation time (about 0.4~0.5 s for 1Hz heart rate). We, thus, choose µ1 = 0.0024 kpa−1 and 
µ2 = 0 for a control case. In the remainder of the paper, we omit the units of µ1 and µ2 for simplicity. 
2.3. Basic Circulation Model and Control Case 
For the circulation model, at the simplest level, we ignore the dynamics of the systemic arterial 
circulation and propose the following basic model, which evolves the left ventricular volume V, aortic 
pressure m, and pump flow n through an axial rotary pump 
dV 1 1 
= (PR − PV)Θ(PR − PV) − (PV − m)Θ(PV − m) − δpn, (11)dt RM RA 
dm 1 1 n 
= − (m − m0) + (PV − m)Θ(PV − m) + δp , (12)dt CSRc CARA CA  
dn δp 
= [PV − m − R∗n + βω2 . (13)dt L∗ 
In Equation (12), m is not coupled to the aortic flow but instead has a parameter m0, which models 
a constant arterial pressure. In Equation (11), PR is the atrial pressure, and for our basic model, we 
take this as a constant value instead of treating it dynamically. Increasing PR and m0 has the effect of 
increasing preload and afterload, respectively. Equations (11) and (13) are exactly the same as those 
in [14,15]. Here, δp is a parameter to denote the presence of a pump, where δp = 1 (δp = 0) represents 
the presence (absence) of a pump. Rc, RM, RA, and R∗ are resistances, CS and CA are compliances, and 
L∗ is inertance. Equation (13) shows that the pump flow n through an axial pump is driven by βω2, 
where β is the pump parameter and ω is the pump speed (not angular frequency), following the same 
notations as in [5,14,15]. Variables and parameters in Equations (1)–(12) are summarized in Tables 1 
and 2, respectively, together with their physiological meaning and their values. 
Table 1. Summary of variables and meanings. 
Variable Physiological Meaning (Unit) 
vc Velocity of the contractile element (s−1) 
εc Strain of the contractile element 
τc Active tension of the contractile element (mmHg) 
kc Stiffness of the contractile element (mmHg) 
σP Passive stress (mmHg) 
u Chemical activity (s−1) 
p Slow electric variable 
q Fast electric variable 
PV Left ventricular pressure (mmHg) 
V Left ventricular volume (mL) 
PR Atrial pressure (mmHg) 
PS Arterial pressure (mmHg) 
m Aortic pressure (mmHg) 
m0 Arterial pressure parameter for the basic model (mmHg) 
Fa Aortic (total) flow (mL/s) 
n Pump flow (mL/s, mL/min) 
δp Pump parameter (1 for pump, 0 for no pump) 
Note that the parameter values for the contractile components (σo, kc, k1, k2) are based on [21–23], while those 
for resistance, compliance, inertance, pump, and are taken from [14,15]. The advantage of this basic model is that 
solutions are not too sensitive to initial conditions due to the nonlinearity of Equations (1)–(10) for mechanical and 
electric activity and the fixed value of PR and m0 in the circulation model in Equations (11) and (12), allowing us to 
find (almost) unique solutions after initial transients disappear. 
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Table 2. Typical model parameters. The pathological case is in square brackets. 
Parameter Value Physiological Meaning 
RA 0.001 mmHg s/mL Aortic valve resistance 
RM 0.005 mmHg s/mL Mitral valve resistance 
RS 0.5 mmHg s/mL Systemic vascular resistance 
RC 0.0398 mmHg s/mL Characteristic resistance 
R∗ 0.3061 − 3.5 (PV − 1 mmHg) Θ(1 mmHg − PV ) Total pump resistance 
CR 4.4 ml/mmHg Left atrial compliance 
CS 1.33 ml/mmHg Systemic compliance 
CA 0.08 ml/mmHg Aortic compliance 
LS 0.0005 mmHg·s2/mL Inertance of blood in aorta 
L∗ 0.0472 mmHg·s2/mL Total pump inertance 
σ0 240 kpa Maximum sarcomere active tension 
k0 120 kpa Maximum sarcomere active elastance 
k1 0.002 kpa Model parameter for a passive tension 
k2 14 kpa [40 kpa] Model parameter for a passive tension 
χ, αl 100 s−1, 10 m−1 Damping parameters in sarcomere 
ω0 100 s
−1 Sarcomere microscale oscillation frequency 
a, b −2100 m·s−2 kpa−1, 6000 m·s Active and passive force parameters 
β0 20 mL−2 Length-tension parameter 
γ 0.6 [0.45] PV parameter 
V0 144/1.5 mL [144 mL] Volume parameter 
µ1, µ2 0.0024 kpa−1, 0 (s·mL)−1 MEF parameters 
2.4. Extended Circulation Model and Control Case 
We extend our basic model by incorporating the dynamics of the systemic arterial circulation, 
specifically by treating the arterial and atrial pressures dynamically. We, thus, include the following 
evolution of Equations (16) and (17) for atrial pressure PR and arterial pressure PS based on the 
Windkessel model in [14,15], while generalizing Equation (12) to Equations (14) and (15) by including 
the aortic flow Fa: 
dm 1 1 n 
= − Fa + (PV − m)Θ(PV − m) + δp , (14)dt CA CARA CA 
dFa m − PS RCFa = − , (15)
dt LS LS 
dPR −PR + PS 1 = − (PR − PV)Θ(PR − PV ), (16)dt CRRS CRRM 
dPS PR − PS Fa = + , (17)
dt CSRS CS 
where RS is the systemic vascular resistance. Thus, for our extended model, we solve Equations 
(14)–(17), (1)–(11) and (13) using parameter values in Table 2. Equations (14)–(17) are identical to those 
in [14,15], with PR = x2, PS = x3, m = x4, Fa = x5 (V = x1, n = x6), with the key difference that we 
calculate V and PV through the coupling to the microscale dynamics instead of using a prescribed 
time-varying elastance formula. Figure 1 shows the electric circuits for the basic model in Figure 1a and 
for the extended model in Figure 1b, where the detailed explanation is provided in the figure caption. 
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ோ೎஼ೄ  in Equation (12). 
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time evolution of ܸ/ ଴ܸ and ߝ௖	in Figure 2a, ߬௖	and ݇௖	in Figure 2b, ݍ, ݌ in Figure 2c, and ௏ܲ	and ݉ 
in Figure 2d, where they all quickly move to a steady state from after only one or two transient 
oscillations. The initial transient is not shown in the P–V loop in Figure 2e. In Figure 2f, we show the 
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the end systolic pressure–volume relation (ESPVR) and shown by a solid red line in Figure 3a for 
steady-state P–V loops obtained for different ݉଴ values.  
Figure 1. (a) The electric circuits for the basic model (a) and for the extended model (b). For the pump 
part, only total (effective) inductance L∗ and resistance R∗ are shown. 
CSHere, DM and DA represent diodes; (a) RE = RC > RC and constant values of PR and PS = m0CA 
are represented by batteries. To recover the basic model from the extended model, we let RC → RE 
m−PS m−m0and PS → m0 i  Equation (15) and obtain the steady solution Fa = = CA. Substituting this RE RcCS 
1in Fa in Equatio  (14) then gives 
m−m0 in Equation (12). CA RcCS 
3. Results and Discussions 
3.1. Control Case in Basic Model 
As an example of a control case, we choose PR = 9 mmHg, m0 = 70 mmHg, b = 6000, γ = 0.6, 
k2 = 14 kpa, αu = 5, V0 = 144/1.5 mL, µ1 = 0.0024, and µ2 = 0. The initial left ventricular volume 
is taken as V(t = 0) = 0.5 V0. For this basic model, solutions do not sensitively depend on other 
initial values, and settle into (almost) unique solutions quickly (after a few seconds). Figure 2 shows 
the time evolution of V/V0 and εc in Figure 2a, τc and kc in Figure 2b, q, p in Figure 2c, and PV and 
m in Figure 2d, where they all quickly move to a steady state from after only one or two transient 
oscillations. The initial transient is not shown in the P–V loop in Figure 2e. In Figure 2f, we show 
PVthe elastance E(t) = by using the volume at zero pressure V∗ ~ 7 mL, which is determined V(t)−V∗ 
from the end systolic pressure–volume relation (ESPVR) and shown by a solid red line in Figure 3a for 
steady-state P–V loops obtained for different m0 values. 
Figure 3a reveal  that the large  the afterload m0, the larger the end systolic volume (ESV) and the 
smaller h  stroke volume (SV = EDV − ESV), where EDV is the end diastolic volume. In Figure 2f, 
the maximum and minimum values of E(t) are about 2.1 and 0.07 mmHg/mL, respectively, similar 
to those that are used for the time-varying elastance model for a normal heart [14,15]. Furthermore, 
the overall shape and time duration between contraction and relaxation are also qualitatively similar 
to those from the time-varying elastance model. This is shown in Figure 3b by magnifying Figure 2f. 
For larger values of m0, the ESPVR is observed to be concave to the volume axis, consistent with the 
experimental results [17,30]. 
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Figure 3. (a) Steady-state pressure–volume (P–V) loops for different afterloads: m0 = 50, 60 and 
70 mmHg; (b) E(t) in Figure 2f for the basic model. Note that a data cursor image shows Emin on 
the y-axis. 
3.2. Control Case in Extended Model 
For the extended model, we use the same parameter values as in Figures 2 and 3 (e.g., k2 = 14 kpa, 
γ = 0.6, V0 = 144/1.5 mL, etc.) and in Table 2. Since the circulation models for PR, m, PS, and Fa 
are linear, solutions have a rather sensitive dependence on initial values in addition to parameter 
values. For Figure 4f, we use initial values PR(0) = 10 mmHg, PS(0) = 70 mmHg, m(0) = 70 mmHg, 
Fa = 90 mL/s, and V(t = 0) = 0.9 V0. In Figure 4f, E(t) is calculated by determining the zero pressure 
volume V∗~7 mL (see Figure 5). Notably, the overall behaviour in Figure 4 is quite similar to that in 
Figure 2. In particular, the solutions go to a steady state form after only one or two transient oscillations 
in Figure 4a–d,f; The initial transient is not shown in the P–V loop in Figure 4e. 
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Figure 5 is equivalent to Figure 3 and shows different P–V loops in a steady state obtained for 
different initial conditions V(0) = [0.4, 0.5, 0.6, 0.7, 0.8, 0.9] mL, as well as a detailed view of E(t) by 
magnifying Figure 4f. Interestingly, in Figure 5a, as V(0) increases, both EDV and ESV increase, similar 
to the effect of different preloads through interactions between preload and afterload, where an increase 
in SV leads to an increase in cardiac output, arterial pressure, and thus, afterload. For V(0) > V0, we 
observe that ESPVR is concave to the volume axis, as in the basic model. Furthermore, Figure 5b is 
quite similar to Figure 3b, with similar maximum (around 2.1 mmHg/mL) and minimum (around 
0.06 mmHg/mL) values. These results underscore that the basic model is a good approximation of the 
extended model for a control case. 
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Figure 5. (a) Steady-state P–V loops for different afterloads: V(0) = [0.4, 0.5, 0.6, 0.7, 0.8, 0.9]V0 
increasing to the right; (b) E(t) in Figure 4f for the extended model. Note that a data cursor image 
shows Emin on the y-axis. 
3.3. Dilated Cardi myopathy 
Dilated cardiomyopathy is one of the main causes of heart failure, where the heart becomes 
enlarged and cannot pump blood effectively. This can result from left ventricular remodeling, such as 
a gradual increase in left ventricular EDV and ESV, wall thinning, and other causes. To model this 
pathological change in heart geometry, we increase the parameter values of k2 and V0 to k2 = 40 kpa, 
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V0 = 144 mL while reducing γ to γ = 0.45 (these parameter values are in square brackets in Table 2) 
and fix all other parameter values. 
3.3.1. Effect of a Pump on Dilated Cardiomyopathy in Basic Model 
For all other parameters, we use the same values as those used in Figures 2 and 3. Figure 6 
shows the time evolution of q (in blue) and p (in red) in the first column, a steady state P–V loop in 
the second column, and the evolution of pump flow n in the last column. The first row is for the case 
without a pump, where the zero pump flow simply means that there is no pump in this case. To see the 
effect of a pump, we choose δp = 1 in Equations (11)–(13) and vary the values of rotary pump speed 
(frequency) ω in Equation (13) as ω = [0, 0.5, 1, 2] × 8000 rpm, presenting results in the second to fifth 
rows in Figure 6. As ω increases, the P–V loop initially shifts to a larger V before shifting to a smaller 
V. The pump flow is negative (associated with an increase in V) for ω = 0 and then becomes positive 
(with the decrease in V) as ω increases. This means that the pump speed needs to exceed the minimum 
value to work effectively (a pump would shut down at the speed below this minimum value). 
In clinical practice, 8000–10,000 rpm is the speed used for an axial rotary blood pump (HeartMate 
II) [10]. A speed < 8000 rpm is used when weaning off the LVAD and a certain protocol is followed, 
gradually decreasing the speed to 6000 rpm to allow ejection of the native heart and analyse its 
performance. In Figure 6, with the increase of ω, the left ventricular pressure PV eventually decreases, 
while aortic pressure m increases. This implies that in a failing heart, a pump will help increase the 
arterial pressure. In the bottom row, we see the decoupling between PV and m for ω = 2 × 8000 rpm. 
These results are similar to those from the time-varying elastance model [14,15]. 
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Figure 6. From top to bottom: δp = 0, ω = 0, 0.5 × 8000, 8000, 2 × 8000 rpm, with δp = 1 for the basic 
model. In each row, the left panel represents PV (blue) and m (red) against time; the middle panel 
represents PV against V; the right panel represents the pump flow n against time. 
3.3.2. Effect of a Pump on Dilated Cardiomyopathy in Extended Model 
For all other parameters, we use the same values as those used in Figures 4 and 5. Figure 7 is 
equivalent to Figure 6. Th  top row is the case without a pump (δp = 0) for a pathological heart; the second 
to the bottom row in Figure 6 sh s a pump (δp = 1) with a pump speed ω = [0, 0.5, 1, 2] × 8000 rpm. 
As i  Figure 6, as ω increases, a P–V loop initially shifts to a larger V before shifting to a smaller V; 
the pump flow becomes negative ( lated to the increase in V) before becoming positive (associated
with the decr ase in V). With the increase of ω, PV (m) eventually decreases (inc as s). In the bot om
row for ω = 2 × 8000 rpm, PV and m decouple without any overlap between the two nd PV ontains
negative pressure. Overall, by comparing Figures 6 and 7, we obs rve e disparity in the haviour of
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n, in particular for ω = 2 × 8000 rpm. For a closer comparison with previous works [14,15], we make 
the pump speed a linearly increasing function of time as ω = 400 t rpm and ω = 8000 + 200 t rpm, 
and show the corresponding results together with the pump speed in the top and bottom panels of 
Figure 8, respectively. Overall, the behaviour of PV, m, and n suddenly changes around ω ~ 12 krpm, 
with the formation of a large envelope of oscillations. This nonmonotonic behaviour corresponds to 
the onset of the suction in [14,15]. For larger ω, PV becomes negative. 
i i i  , ,     
disparity in the behaviour of ݊, in particular for ߱ = 2	 × 	8000	rpm. For a closer comparison with 
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400	t	rpm and ߱ = 8000 + 200	t	rpm, and show the corresponding results together with the pump 
speed in the top and bottom panels of Figure 8, respectively. Overall, the behaviour of	 ௏ܲ	, ݉, and 
݊	suddenly changes around ߱	~	12 krpm, with the formation of a large envelope of oscillations. This 
nonmonotonic behaviour corresponds to the onset of the suction in [14,15]. For larger ߱, ௏ܲ becomes 
negative.  
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For a closer comparison with previous works [14,15], we make the pump speed a linearly 
increasing function of time as ω = 400 t rpm and ω = 8000 + 200 t rpm, and show the corresponding 
results together with the pump speed in the top and bottom panels of Figure 8, respectively. Overall, 
the behaviour of PV, m, and n suddenly changes around ω ~ 12 krpm, with the formation of a large 
envelope of oscillations. This nonmonotonic behaviour corresponds to the onset of the suction in [14,15]. 
For larger ω, PV becomes negative. 
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Further, to compare our results with in vivo animal data during rotary pump assistance 
100t(Figure 79.13 in [14], Figures 10 and 11 in [15]), we show results by using ω = 8000 + 3 in 
Figure 9. In particular, the left bottom panel sho s that the pump flow exhibits a large envelope of 
oscillations, while its mean v lue l ly increases over time; the on et of suction occurs at the pump 
speed ω ≈ 12 krpm. This is very similar to the behaviour of he p mp fl w from in vivo data shown in 
Figu e 79.13 in [14]. 
Here, a substantial oscillation envelope is seen, with the mean value increasing with time before 
the ons t of s ction, which occurs at a similar pump speed of ω = 12.5 krpm. In comparison, the 
evolution the pump flow from the time-v ying elastance model shown in Figure 79.12 in [14] 
behaves differently; there is a significant reduction in the oscillation nvel pe without much increase 
in its mean value before the onset of suction, and the onset of suction takes place at a c  greater 
pump speed of ω ≈ 15.5 krpm. 
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Figure 9. Here, ω = 8000 + 100t/3 rpm for the extended model. 
Therefore, our results are in much better agreement with in vivo data than the prediction from the 
time-varying elastance model in [14,15]. The agreement with in vivo data is also better in the extended 
model than the basic model, as aortic flow (its interaction with a pump) is not treated dynamically in 
the basic model (see Figure 10). These results highlight the importance of self-consistent treatment of 
the LVAD–heart interactions in simulating clinical scenarios, with a view to treat ent optimization 
and outcome prediction. 
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Finally, we note that the direct comparison of our results with those from more advanced 
(distributed) models with the LVAD support [19] is difficult. if not impossible, because of the use of 
different variables or parameters and the lack of a systematic study on these advanced models (due to 
high computational cost). 
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better agreement compared with the time-varying elastance model in [14,15]. 
  
0 20 40 60 80 100
time
5
10
15
20
25
30
pu
m
p 
sp
ee
d 
(k
rp
m
)
0 20 40 60 80 100
time (s)
0
20
40
60
80
100
120
pu
m
p 
flo
w
 (l
/m
in
)
0 20 40 60 80 100
time (s)
0
50
100
150
200
250
300
P
V 
(b
lu
e)
, m
 (m
m
H
g)
60 80 100 120 140 160 180
V (ml)
0
20
40
60
80
P
V 
(m
m
H
g)
Figure 10. ere, ω     t r  f r t e sic el (c re  it  i res  a  9 for the 
extended odel). 
3.4. Summary 
The pressure–volume relation plays a key role in cardiovascular modeling, and the traditional 
approach heavily relies on the time-varying elastance concept [5,11–15], in which the pressure to 
volume ratio is prescribed as a (double) periodic function of time. In particular, lumped-parameter 
models combined with pressure–volume loop analysis and time-varying elastance are very effective in 
simulating clinical scenarios, with a view to treatment optimization and outcome prediction [6,11]. 
However, the time-varying elastance concept has limited validity, as it cannot address cardiac 
self-organization and its breakdown, especially for a mechanically supported left ventricle, where its 
application for the analysis of LVAD–heart interactions has been questioned. Therefore, our aim was to 
develop a method that is at least as good as lumped-parameter modeling, but which enables us to 
investigate cardiac self-organization and the interaction between the cardiac system and LVAD. 
To this end, we developed a synergistic model that couples mechanical, electric, and chemical 
activity on microscale sarcomere and macroscale heart levels, and which predicted the pressure–volume 
relation of the left ventricle consistently. In a control case without LVAD, we showed that both basic 
and extended models reproduced the left ventricular pressure–volume relation, which is similar to 
what is obtained from the time-varying elastance model (e.g., comparing Figures 2–5 with Figure 79.8b 
in [14]). 
We then considered a failing left ventricle by choosing parameter values to model dilated 
cardiomyopathy and investigated the interaction between a failing left ventricle and the circulation in 
the presence of a rotary pump by including the coupling between the aortic pressure and the pump 
flow in an axial rotary pump. For a sufficiently large pump speed, the stroke volume of the left 
ventricle increases, while its pressure and aortic pressure are decoupled with the increase (decrease) 
in the pressure of the aorta (left ventricle), similar to the finding from the time-varying elastance 
model. Furthermore, our extended model worked better than the time-varying elastance model in 
reproducing in vivo animal data with a rotary pump (see Figure 9), in particular in the overall shape 
(large envelope) of oscillations of the pump flow and the pump speed for the onset of suction, with a 
better agreement compared with the time-varying elastance model in [14,15]. 
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4. Conclusions 
We conclude that our synergistic model is a valid and better alternative to the time-varying 
elastance model considering that it addresses all the key aspects involved in terms of the overall P–V 
loop shape and the interaction between LVAD and circulation. In particular, it consistently incorporates 
the coupling between the mechanical and electric activity and can be used to explore MEF, which 
would otherwise have been impossible in real experiments or with the time-varying elastance model. 
The importance of self-consistent treatment of the LVAD–heart interactions was highlighted. Finally, 
we note that our model can also be extended to study the interaction between the left ventricle and 
atria [20], as well as the effect of LVAD on the right ventricle failure [31] at the simplest level, but yet is 
close to real life scenarios incorporating the interaction between the circulation, LVAD, and microscale 
dynamics. Future work will also explore the incorporation of central and peripheral extracorporeal 
membrane oxygenation (ECMO). 
Limitation of our study: Given the simplicity of our lumped parameter model based on a set of 
ordinary differential equations, our model cannot inform us how our variables are distributed in space 
(e.g., waves), any consequences of their inhomogeneity, or the effect of boundaries. Furthermore, given 
the limited number of parameters, our model reproduces only a qualitatively similar shape of a P–V 
loop of an individual, but not its exact shape. 
Author Contributions: Conceptualization, E.-j.K. and M.C.; methodology, E.-j.K.; formal analysis, E.-j.K.; 
investigation, E.-j.K. and M.C.; writing, E.-j.K. and M.C. All authors have read and agreed to the published version 
of the manuscript. 
Funding: This research received no external funding. 
Acknowledgments: We are very grateful to Sorine for valuable discussions about his BCS and cylindrical heart 
models, related work in [21–23] and cardiac synchrony, and also for providing references [23]. We are also 
grateful to Simaan for valuable discussions about his work in [14,15] and for providing relevant parameter and 
initial values. 
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1.	 Haken, H. Information and Self-Organization: A Macroscopic Approach to Complex Systems; Springer Series in 
Synergetics; Springer: Berlin, Heidelberg, 2006. 
2.	 Wright, T.; Twaddle, J.; Humphries, C.; Hayes, S.; Kim, E. Variability and degradation of self-organization in 
self-sustained oscillators. Math. Biosci. 2016, 273, 57–69. [CrossRef] [PubMed] 
3.	 Sheikh, F.H.; Russell, S.D. HeartMate® II continuous-flow left ventricular assist system. Expert Rev. 
Med. Devices 2011, 8, 811–821. [CrossRef] [PubMed] 
4.	 Tuzun, E.; Roberts, K.; Cohn, W.E.; Sargin, M.; Gemmato, C.J.; Radovancevic, B.; Frazier, O.H. In vivo 
evaluation of the HeartWare centrifugal ventricular assist device. Tex. Heart Inst. J. 2007, 34, 406–411. 
5.	 Capoccia, M. Development and Characterization of the Arterial Windkessel and Its Role during Left 
Ventricular Assist Device Assistance. Artif. Organs 2015, 39, 138–153. [CrossRef] 
6.	 Capoccia, M.; Marconi, S.; Singh, S.A.; Pisanelli, D.M.; De Lazzari, C. Simulation as a preoperative planning 
approach in advanced heart failure patients: A retrospective clinical analysis. Biomed. Eng. Online 2018, 17, 
52. [CrossRef] 
7.	 Ferrari, G.; Di Molfetta, A.; Zieliñski, K.; Fresiello, L. Circulatory modelling as a clinical decision support and 
an educational tool. Biomed. Data J. 2015, 1, 45–50. [CrossRef] 
8.	 Griffith, B.P.; Kormos, R.L.; Borovetz, H.S.; Litwak, K.; Antaki, J.F.; Poirier, V.L.; Butler, K.C. HeartMate II left 
ventricular assist system: From concept to first clinical use. Ann. Thorac. Surg. 2001, 71, 116–120. [CrossRef] 
9.	 Giridharan, G.A.; Skliar, M.; Olsen, D.B.; Pantalos, G.M. Modeling and control of a brushless DC axial flow 
ventricular assist device. Am. Soc. Artif. Intern. Organs (ASAIO) J. 2001, 48, 272–289. [CrossRef] 
10.	 Moazami, N.; Fukamachi, K.; Kobayashi, M.; Smedira, N.G.; Hoercher, K.J.; Massiello, A.; Lee, S.J.; 
Horvath, D.J.; Starling, R.C. Axial and centrifugal continuous-flow rotary pumps: A translation from pump 
mechanics to clinical practice. J. Heart Lung Transplant. 2013, 32, 1–11. [CrossRef] 
Bioengineering 2020, 7, 1	 16 of 16 
11.	 Casas, B.; Lantz, J.; Viola, F.; Cedersund, G.; Bolger, A.F.; Carlhäll, C.J.; Karlsson, M.; Ebbers, T. Bridging 
the gap between measurements and modelling: A cardiovascular functional avatar. Sci. Rep. 2017, 7, 1–15. 
[CrossRef] 
12.	 Suga, H.; Sagawa, K. Instantaneous pressure-volume relationships and their ratio in the excised, supported 
canine left ventricle. Circ. Res. 1974, 35, 117–126. [CrossRef] [PubMed] 
13.	 Broomé, M.; Maksuti, E.; Bjällmark, A.; Frenckner, B.; Janerot-Sjöberg, B. Closed-loop real-time simulation 
model of hemodynamics and oxygen transport in the cardiovascular system. Biomed. Eng. Online 2013, 12, 
69. [CrossRef] [PubMed] 
14.	 Simaan, M.A. Rotary heart assist devices. In Springer Handbook of Automation; Nof, S.Y., Ed.; Springer: Berlin, 
German, 2009. 
15.	 Simaan, M.A.; Ferreira, A.; Chen, S.; Antaki, J.F.; Galati, D.G. A dynamical state space representation 
and performance analysis of feedback-controlled rotary left ventricular assist device. IEEE Trans. Control. 
Syst. Technol. 2019, 17, 15–28. [CrossRef] 
16.	 Shi, Y.; Korakianitis, T. Numerical Simulation of Cardiovascular Dynamics with Left Heart Failure and 
In-series Pulsatile Ventricular Assist Device. Artif. Organs 2006, 30, 929–948. [CrossRef] [PubMed] 
17.	 Claessens, T.E.; Georgakopoulos, D.; Afanasyeva, M.; Vermeersch, S.J.; Millar, H.D.; Stergiopulos, N.; 
Westerhof, N.; Verdonck, P.R.; Segers, P. Nonlinear isochrones in murine left ventricular pressure-volume 
loops: How well does the time-varying elastance concept hold? Am. J. Physiol. Heart Circ. Physiol. 2006, 290, 
1474–1483. [CrossRef] 
18.	 Vandenberghe, S.; Segers, P.; Steendijk, P.; Meyns, B.; Dion, R.A.E.; Antaki, J.F.; Verdonck, P. Modelling 
Ventricular Function during Cardiac Assist: Does Time-Varying Elastance Work? Am. Soc. Artif. Intern. 
Organs (ASAIO) J. 2006, 52, 4–8. [CrossRef] 
19.	 McCormick, M.; Nordsletten, D.A.; Kay, D.; Smith, N.P. Simulating left ventricular fluid-solid mechanics 
through the cardiac cycle under LVAD support. J. Comput. Phys. 2013, 244, 80–96. [CrossRef] 
20.	 CircAdapt. Available online: http://www.circadapt.org/publications (accessed on 8 August 2019). 
21.	 Bestel, J.; Clément, F.; Sorine, M. A biomechanical model of muscle contraction. In International Conference on 
Medical Image Computing and Computer-Assisted Intervention; Goos, G., Hartmanis, J., van Leeuwen, J., Eds.; 
Springer: Berlin, Germany, 2001; pp. 1159–1161. 
22.	 Sainte-Marie, J.; Chapelle, D.; Cimrman, R.; Sorine, M. Modeling and estimation of the cardiac 
electromechanical activity. Comput. Struct. 2006, 84, 1743–1759. [CrossRef] 
23.	 Bestel, J. Modèle diffréntiel de la contraction musculaire contrôlée: Application au système cardiovasculaire. 
Ph.D. Thesis, Université Paris 9, Paris, France, 2000. 
24.	 FitzHugh, R. Impulses and physiological states in theoretical models of nerve membrane. Biophys. J. 1962, 1, 
445–466. [CrossRef] 
25.	 Knudsen, Z.; Holden, A.; Brindley, J. Qualitative modeling of mechano-electrical feedback in aventricular 
cell. Bull. Math. Biol. 1997, 6, 115–181. 
26.	 Tse, G.; Wong, S.T.; Tse, V.; Lee, Y.T.; Lin, H.Y.; Yeo, J.M. Cardiac dynamics: Alternans and arhythmogenesis. 
J. Arrhythm. 2016, 32, 411–417. [CrossRef] [PubMed] 
27.	 Franz, M.R. Mechano-electrical feedback in ventricular myocardium. Cardiovasc. Res. 1996, 32, 15–24. 
[CrossRef] 
28.	 Lab, M.J.; Allen, D.G.; Orchard, C.H. The effects of shortening on myoplasmic calcium concentration and 
action potential in mammalian ventricular muscle. Circ. Res. 1984, 55, 825–829. [CrossRef] 
29.	 Collet, A.; Bragard, J.; Dauby, P.C. Temperature, geometry, and bifurcations in the numerical modeling of the 
cardiac mechano-electric feedback. Chaos Interdiscip. J. Nonlinear Sci. 2017, 27, 093924. [CrossRef] 
30.	 Burkhoff, D.; Sugiura, S.; Yue, D.T.; Sagawa, K. Contractility-dependent curvilinearity of endsystolic 
pressure-volume relations. Am. J. Physiol. Heart Circ. Physiol. 1987, 252, 1218–1227. [CrossRef] 
31.	 Scardulla, F.; Agnese, V.; Romano, G.; Di Gesaro, G.; Sciacca, S.; Bellavia, D.; Clemenza, F.; Pilato, M.; 
Pasta, S. Modeling right ventricle failure after continuous flow left ventricular assist device: A biventricular 
finite-element and lumped-parameter analysis. Cardiovasc. Eng. Technol. 2018, 9, 427–437. [CrossRef] 
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
